Dairy products and the French paradox: Could alkaline phosphatases play a role?

Medical Hypotheses

Volumn 92, Issue , 2016, Pages 7-11

  Lallès, Jean Paul ^a,b  

^a CEMAGREF   (France)

^b Human Nutrition Research Centre West   (France)

Author keywords

Alkaline phosphatase; Cheese; Dairy products; French paradox; Milk

Indexed keywords

ALKALINE PHOSPHATASE; FAT INTAKE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; DAIRY PRODUCT; ENZYME ACTIVITY; FAT INTAKE; FEEDING BEHAVIOR; FOOD ANALYSIS; FRENCH PARADOX; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; INTESTINE CELL; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; SIGNAL TRANSDUCTION; ANIMAL; CARDIOVASCULAR DISEASES; CHEESE; DIET; ENZYMOLOGY; FERMENTATION; FOOD CONTROL; FRANCE; INTESTINE; METABOLISM; MILK; PASTEURIZATION; THEORETICAL MODEL; WINE;

ALKALINE PHOSPHATASE; ANIMALS; CARDIOVASCULAR DISEASES; CHEESE; DAIRY PRODUCTS; DIET; DIETARY FATS; FERMENTATION; FOOD MICROBIOLOGY; FRANCE; HUMANS; INTESTINES; MILK; MODELS, THEORETICAL; PASTEURIZATION; WINE;

EID: 84963959825     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2016.04.033     Document Type: Article

References (74)

1. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339(8808):1523-1526.
2. OECD.Health at a glance OECD indicators 2015, OECD Publishing. 10.1787/health_glance-2015-en.
3. Biagi M., Bertelli A.A. Wine, alcohol and pills: what future for the French paradox?. Life Sci 2015, 131:19-22.
4. Artero A., Artero A., Tarín J.J., Cano A. The impact of moderate wine consumption on health. Maturitas 2015, 80(1):3-13.
5. Hansel B., Roussel R., Diguet V., Deplaude A., Chapman M.J., Bruckert E. Relationships between consumption of alcoholic beverages and healthy foods: the French supermarket cohort of 196,000 subjects. Eur J Prev Cardiol 2015, 22(2):215-222.
6. Petyaev I.M., Bashmakov Y.K. Could cheese be the missing piece in the French paradox puzzle?. Med Hypotheses 2012, 79(6):746-749.
7. Malinowski J., Klempt M., Clawin-Rädecker I., Lorenzen P.C., Meisel H. Identification of a NFκB inhibitory peptide from tryptic β-casein hydrolysate. Food Chem 2014, 165:129-133.
8. Plé C., Breton J., Richoux R., Nurdin M., Deutsch S.M., Falentin H., et al. Combining selected immunomodulatory Propionibacterium freudenreichii and Lactobacillus delbrueckii strains: reverse engineering development of an anti-inflammatory cheese. Mol Nutr Food Res 2016, 60(4):935-948.
9. Durán Agüero S., Torres García J., Sanhueza Catalán.J. Consumption of cheese and milk and chronic diseases associated with obesity: friend or foe?. Nutr Hosp 2015, 32(1):61-68.
10. Lallès J.P. Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev 2010, 68(6):323-332.
11. Lallès J.P. Intestinal alkaline phosphatase: novel functions and protective effects. Nutr Rev 2014, 72(2):82-94.
12. Koivisto T., Salaspuro M. Effects of acetaldehyde on brush border enzyme activities in human colon adenocarcinoma cell line Caco-2. Alcohol Clin Exp Res 1997, 21(9):1599-1605.
13. Nunes C., Ferreira E., Freitas V., Almeida L., Barbosa R.M., Laranjinha J. Intestinal anti-inflammatory activity of red wine extract: unveiling the mechanisms in colonic epithelial cells. Food Funct 2013, 4(3):373-383.
14. Joo N.S., Yang S.W., Park S.J., Choi S.J., Song B.C., Yeum K.J. Milk consumption and Framingham risk score: analysis of the Korea national health and nutrition examination survey data (2008-2011). Yonsei Med J 2016, 57(1):197-202.
15. Moreno L.A., Gottrand F., Huybrechts I., Ruiz J.R., González-Gross M., DeHenauw S., et al. Nutrition and lifestyle in european adolescents: the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) study. Adv Nutr 2014, 5(5):615-623.
16. Martins M.L., Kac G., Silva R.A., Bettiol H., Barbieri M.A., Cardoso V.C., et al. Dairy consumption is associated with a lower prevalence of metabolic syndrome among young adults from Ribeirão Preto. Brazil Nutr 2015, 31(5):716-721.
17. Hirahatake K.M., Slavin J.L., Maki K.C., Adams S.H. Associations between dairy foods, diabetes, and metabolic health: potential mechanisms and future directions. Metabolism 2014, 63(5):618-627.
18. Astrup A. Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies. Am J Clin Nutr 2014, 99(5 Suppl):1235-1242.
19. Babio N., Becerra-Tomás N., Martínez-González M.Á., Corella D., Estruch R., Ros E., et al. Consumption of yogurt, low-fat milk, and other low-fat dairy products is associated with lower risk of metabolic syndrome incidence in an elderly mediterranean population. J Nutr 2015, 145(10):2308-2316.
20. Tapsell L.C. Fermented dairy food and CVD risk. Br J Nutr 2015, 113(Suppl 2):131-135.
21. Ericson U., Hellstrand S., Brunkwall L., Schulz C.A., Sonestedt E., Wallström P., et al. Food sources of fat may clarify the inconsistent role of dietary fat intake for incidence of type 2 diabetes. Am J Clin Nutr 2015, 101(5):1065-1080.
22. Qin L.Q., Xu J.Y., Han S.F., Zhang Z.L., Zhao Y.Y., Szeto I.M. Dairy consumption and risk of cardiovascular disease: an updated meta-analysis of prospective cohort studies. Asia Pac J Clin Nutr 2015, 24(1):90-100.
23. Sadeghi M., Khosravi-Boroujeni H., Sarrafzadegan N., Asgary S., Roohafza H., Gharipour M., et al. Cheese consumption in relation to cardiovascular risk factors among Iranian adults- IHHP Study. Nutr Res Pract 2014, 8(3):336-341.
24. Astrup A. A changing view on saturated fatty acids and dairy: from enemy to friend. Am J Clin Nutr 2014, 100(6):1407-1408.
25. Morio B., Fardet A., Legrand P., Lecerf J.M. Involvement of dietary saturated fats, from all sources or of dairy origin only, in insulin resistance and type 2 diabetes. Nutr Rev 2016, 74(1):33-47.
26. Drehmer M., Pereira M.A., Schmidt M.I., Alvim S., Lotufo P.A., Luft V.C., et al. Total and full-fat, but not low-fat, dairy product intakes are inversely associated with metabolic syndrome in adults. J Nutr 2016, 146(1):81-89.
27. Kratz M., Baars T., Guyenet S. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr 2013, 52(1):1-24.
28. Praagman J., Franco O.H., Ikram M.A., Soedamah-Muthu S.S., Engberink M.F., van Rooij F.J., et al. Dairy products and the risk of stroke and coronary heart disease: the Rotterdam study. Eur J Nutr 2015, 54(6):981-990.
29. Ghanei L., Ziaee A., Rostami P., Oveisi S., Esmailzadehha N., Kazemifar A.M., et al. Association of serum 25-hydroxyvitamin d levels and vitamin D dietary intake with metabolic syndrome: a case control study. J Res Health Sci 2015, 15(1):32-36.
30. Strange R.C., Shipman K.E., Ramachandran S. Metabolic syndrome: a review of the role of vitamin D in mediating susceptibility and outcome. World J Diabetes 2015, 6(7):896-911.
31. Tremblay A., Gilbert J.A. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 2009, 28(Suppl 1):91-102.
32. Shin S.K., Kim M.K., Lee Y.H., Shin D.H., Shin M.H., Chun B.Y., et al. The cross-sectional relationship between dietary calcium intake and metabolic syndrome among men and women aged 40 or older in rural areas of Korea. Nutr Res Pract 2015, 9(3):328-335.
33. Tian D.Y., Tian J., Shi C.H., Song B., Wu J., Ji Y., et al. Calcium intake and the risk of stroke: an up-dated meta-analysis of prospective studies. Asia Pac J Clin Nutr 2015, 24(2):245-252.
34. Torres M.R., Sanjuliani A.F. Does calcium intake affect cardiovascular risk factors and/or events?. Clinics (Sao Paulo) 2012, 67(7):839-844.
35. Michaëlsson K., Melhus H., Warensjö Lemming E., Wolk A., Byberg L. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ 2013, 346:f228.
36. Xiao Q., Murphy R.A., Houston D.K., Harris T.B., Chow W.H., Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med 2013, 173(8):639-646.
37. Geleijnse J.M., Vermeer C., Grobbee D.E., Schurgers L.J., Knapen M.H., van der Meer I.M., et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam study. J Nutr 2004, 134(11):3100-3105.
38. Gast G.C., de Roos N.M., Sluijs I., Bots M.L., Beulens J.W., Geleijnse J.M., et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 2009, 19(7):504-510.
39. Shimizu Y., Nakazato M., Sekita T., Kadota K., Yamasaki H., Takamura N., et al. Association between alkaline phosphatase and hypertension in a rural Japanese population: the Nagasaki Islands study. J Physiol Anthropol 2013, 32(1):10.
40. Shimizu Y., Imano H., Ohira T., Kitamura A., Kiyama M., Okada T., et al. Alkaline phosphatase and risk of stroke among Japanese: the circulatory risk in communities study (CIRCS). J Stroke Cerebrovasc Dis 2013, 22(7):1046-1055.
41. Wannamethee S.G., Sattar N., Papcosta O., Lennon L., Whincup P.H. Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arterioscler Thromb Vasc Biol 2013, 33(5):1070-1076.
42. Cani P.D., Delzenne N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009, 15(13):1546-1558.
43. Geurts L., Neyrinck A.M., Delzenne N.M., Knauf C., Cani P.D. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes 2014, 5(1):3-17.
44. Kaliannan K., Hamarneh S.R., Economopoulos K.P., Nasrin Alam S., Moaven O., Patel P., et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci U S A 2013, 110(17):7003-7008.
45. de La Serre C.B., Ellis C.L., Lee J., Hartman A.L., Rutledge J.C., Raybould H.E. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 2010, 299(2):440-448.
46. Bovee-Oudenhoven I., Termont D., Dekker R., Van der Meer R. Calcium in milk and fermentation by yoghurt bacteria increase the resistance of rats to Salmonella infection. Gut 1996, 38(1):59-65.
47. Ghoshal S., Witta J., Zhong J., de Villiers W., Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009, 50(1):90-97.
48. Kaliannan K., Wang B., Li X.Y., Kim K.J., Kang J.X. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci Rep 2015, 5:11276.
49. Takase S., Goda T. Effects of medium-chain triglycerides on brush border membrane-bound enzyme activity in rat small intestine. J Nutr 1990, 120(9):969-976.
50. Glickman R.M., Alpers D.H., Drummey G.D., Isselbacher K.J. Increased lymph alkaline phosphatase after fat feeding: effects of medium chain triglycerides and inhibition of protein synthesis. Biochim Biophys Acta 1970, 201(2):226-235.
51. Nakano T., Inoue I., Alpers D.H., Akiba Y., Katayama S., Shinozaki R., et al. Role of lysophosphatidylcholine in brush-border intestinal alkaline phosphatase release and restoration. Am J Physiol Gastrointest Liver Physiol 2009, 297(1):207-214.
52. Shin J., Carr A., Corner G.A., Tögel L., Dávalos-Salas M., Tran H., et al. The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner. J Biol Chem 2014, 289(36):25306-25316.
53. Fukushima K., Sasaki I., Hasegawa H., Takahashi K., Naito H., Funayama Y., et al. Sodium butyrate-induced liver-type alkaline phosphatase activity in a small intestinal epithelial cell line, IEC6. Dig Dis Sci 1998, 43(5):1116-1123.
54. Fukushima K., Sasaki I., Ki Takahashi., Naito H., Ogawa H., Sato S., et al. Lipopolysaccharide exhibits synergistic enhancement of butyrate-induced and retinoic acid-mediated alkaline phosphatase activity on small intestinal epithelial cell line, IEC-6. Digestion 1998, 59(6):683-688.
55. Ji Y., Wu Z., Dai Z., Sun K., Wang J., Wu G. Nutritional epigenetics with a focus on amino acids: implications for the development and treatment of metabolic syndrome. J Nutr Biochem 2016, 27:1-8.
56. Nikawa T., Rokutan K., Nanba K., Tokuoka K., Teshima S., Engle M.J., et al. Vitamin A up-regulates expression of bone-type alkaline phosphatase in rat small intestinal crypt cell line and fetal rat small intestine. J Nutr 1998, 128(11):1869-1877.
57. Vijayalakshhmi B., Sesikeran B., Udaykumar P., Kalyanasundaram S., Raghunath M. Effects of vitamin restriction and supplementation on rat intestinal epithelial cell apoptosis. Free Radic Biol Med 2005, 38(12):1614-1624.
58. Bressenot A., Pooya S., Bossenmeyer-Pourie C., Gauchotte G., Germain A., Chevaux J.B., et al. Methyl donor deficiency affects small-intestinal differentiation and barrier function in rats. Br J Nutr 2013, 109(4):667-677.
59. Rosenthal I., Bernstein S., Rosen B. Alkaline phosphatase activity in Penicillium roqueforti and in blue-veined cheeses. J Dairy Sci 1996, 79(1):16-19.
60. Petyaev I.M., Zigangirova N.A., Kobets N.V., Tsibezov V., Kapotina L.N., Fedina E.D., et al. Roquefort cheese proteins inhibit Chlamydia pneumoniae propagation and LPS-induced leukocyte migration. Sci World J 2013, 2013:140591.
61. Buts J.P., Dekeyser N., Stilmant C., Delem E., Smets F., Sokal E. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr Res 2006, 60(1):24-29.
62. Bianchi-Salvadori B., Camaschella P., Cislaghi S. Rapid enzymatic method for biotyping and control of lactic acid bacteria used in the production of yogurt and some cheeses. Int J Food Microbiol 1995, 27(2-3):253-261.
63. Basson M.D., Emenaker N.J., Hong F. Differential modulation of human (Caco-2) colon cancer cell line phenotype by short chain fatty acids. Proc Soc Exp Biol Med 1998, 217(4):476-483.
64. Delgado F.J., González-Crespo J., Cava R., Ramírez R. Free fatty acids and oxidative changes of a raw goat milk cheese through maturation. J Food Sci 2011, 76(4):669-673.
65. Thierry A., Deutsch S.M., Falentin H., Dalmasso M., Cousin F.J., Jan G. New insights into physiology and metabolism of Propionibacterium freudenreichii. Int J Food Microbiol 2011, 149(1):19-27.
66. Morton R.K. Alkaline phosphatase of milk. 1. Association of the enzyme with a particulate lipoprotein complex. Biochem J 1953, 55(5):786-795.
67. Bingham E.W., Malin E.L. Alkaline phosphatase in the lactating bovine mammary gland and the milk fat globule membrane. Release by phosphatidylinositol-specific phospholipase C. Comp Biochem Physiol B 1992, 102(2):213-218.
68. Lorenzen P.C., Martin D., Clawin-Rädecker, Barth K., Knappstein K. Activities of alkaline phosphatase, γ-glutamyltransferase and lactoperoxidase in cow, sheep and goat's milk in relation to heat. Small Rum Res 2010, 89:18-23.
69. Bender B., Baranyi M., Kerekes A., Bodrogi L., Brands R., Uhrin P., et al. Recombinant human tissue non-specific alkaline phosphatase successfully counteracts lipopolysaccharide induced sepsis in mice. Physiol Res 2015, 64(5):731-738.
70. Rankin S.A., Christiansen A., Lee W., Banavara D.S., Lopez-Hernandez A. Invited review: the application of alkaline phosphatase assays for the validation of milk product pasteurization. J Dairy Sci 2010, 93(12):5538-5551.
71. Montel M.C., Buchin S., Mallet A., Delbes-Paus C., Vuitton D.A., Desmasures N., et al. Traditional cheeses: rich and diverse microbiota with associated benefits. Int J Food Microbiol 2014, 177:136-154.
72. Coburn S.P., Mahuren J.D., Pauly T.A., Ericson K.L., Townsend D.W. Alkaline phosphatase activity and pyridoxal phosphate concentrations in the milk of various species. J Nutr 1992, 122(12):2348-2353.
73. Christen L., Lai C.T., Hartmann B., Hartmann P.E., Geddes D.T. Ultraviolet-C irradiation: a novel pasteurization method for donor human milk. PLoS ONE 2013, 8(6):e68120.
74. Malo M.S. A high level of intestinal alkaline phosphatase is protective against type 2 diabetes mellitus irrespective of obesity. EBioMedicine 2015, 2(12):2016-2023.